A randomized, double-blind, placebo-controlled trial of vitamin C iontophoresis in melasma

Dermatology. 2003;206(4):316-20. doi: 10.1159/000069943.

Abstract

Background: Vitamin C is known to both inhibit melanin formation and reduce oxidized melanin. However, vitamin C does not easily penetrate the skin. In this study, vitamin C iontophoresis was employed in order to enhance vitamin C penetration.

Objective: The purpose of this study was to evaluate the efficacy of vitamin C iontophoresis for melasma patients.

Methods: Twenty-nine females with melasma were enrolled. For iontophoresis, a vitamin C solution was applied to one side of the face, while distilled water was applied to the other side as a control. The L (luminance) value was measured by a colorimeter to obtain an objective pigmentation parameter.

Results: Twelve weeks after iontophoresis, the colorimeter of the treated site showed a significant decrease in the L value (from 4.60 to 2.78, p = 0.002), compared to that of the control site (from 4.45 to 3.87, p = 0.142).

Conclusion: Vitamin C iontophoresis may be an effective treatment modality for melasma.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Antioxidants / therapeutic use*
  • Ascorbic Acid / therapeutic use*
  • Computer Graphics
  • Data Interpretation, Statistical
  • Double-Blind Method
  • Female
  • Humans
  • Iontophoresis / methods*
  • Melanosis / drug therapy*
  • Middle Aged
  • Neurocutaneous Syndromes / drug therapy*
  • Research Design
  • Treatment Outcome

Substances

  • Antioxidants
  • Ascorbic Acid